Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT06523543
Recruiting Observational

Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells

NCT06523543 · tracked via the Priya Life Science France tracker
Sponsor
University Hospital, Montpellier
Phase
Observational
Started
2024-11-19
Last updated
2026-03-13

Condition(s) studied

Pregnant Women

Investigational drug(s) / intervention(s)

Inclusion (Visit 1 - Week 7-16)Second semester of pregnancy (Visit 2 - Week 20-24)Third semester of pregnancy (Visit 3- Week 34)

Inclusion (Visit 1 - Week 7-16): Extraction of cervico-vaginal sampling

Second semester of pregnancy (Visit 2 - Week 20-24): Ultrasound examination (determination of chromosomal sex)

Third semester of pregnancy (Visit 3- Week 34): Ultrasound examination (determination of chromosomal sex) if this has not be done during the Visit 2 or if a new determination correcting the previous one is provided.

Study summary

Demonstrate the efficacy of an ultra-early, non-invasive prenatal diagnostic method adaptable to various genetic indications to detect fetal chromosomal abnormalities.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Pregnant woman * Singleton pregnancy * Pregnancy between 7 and 16 weeks of amenorrhea (WA) * Woman ≥ 18 years * Woman who has signed an informed consent * Woman affiliated to social security or equivalent scheme Exclusions Criteria: * Person under guardianship or curatorship * Person placed under legal protection * Person unable to provide the participant with informed consent.

Primary outcome measure(s)

  • Establish an ultra-early detection method — Visit 2 (Week 20-24)
    Collect fetal phenotypic data obtained during the second or the 3rd trimester via ultrasound echography

Trial sites (1)

FacilityCityRegionStatus
CHU de Montpellier Montpellier France Recruiting

More University Hospital, Montpellier trials in France

Spinal Cord Injury: Impact on Sensory, Motor, Behavioral and Cognitive Functions Starting soon
Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk Recruiting
Chronic Airway Disease, Mucus Rheology and Exacerbations Recruiting
Evaluation of Acute Endovascular Treatment in Symptomatic Isolated Cervical Internal Carotid Artery Occlusion (ETICA) Recruiting
Evaluation of the Absence of Intraoperative Bladder Catheterization in Case of Planned Cesarean Section Recruiting

Other trials for the same condition

Evaluation of the Absence of Intraoperative Bladder Catheterization in Case of Planned Cesarean Section Recruiting
Outpatient Induction of Labour Using a Double Balloon Transcervical Catheter in Low-risk Pregnant Women: a Two-centre Open Prospective Randomised Controlled Trial - OutCRIB Recruiting
THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin Recruiting
Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06523543 on ClinicalTrials.gov ↗ ← All trials in France